Table 1.
Demographics of patients undergoing pancreaticoduodenectomy
| Variable | Total (%) | Blumgart PJa (%) | PGb (%) | P Value |
|---|---|---|---|---|
| n | 206 | 103 | 103 | |
| Gender | 0.484 | |||
| Male | 112 (54) | 59 (57) | 53 (52) | |
| Age, y/o | 0.533 | |||
| Median | 65 (27–90) | 65 (30–87) | 66 (27–90) | |
| Mean ± SD | 64 ± 13 | 65 ± 12 | 63 ± 15 | |
| Primary tumor origin | 0.795 | |||
| Pancreatic head adenocarcinoma | 66 (32) | 36 (35) | 30 (29) | |
| Ampullary adenocarcinoma | 65 (32) | 34 (33) | 31 (30) | |
| Distal CBD c adenocarcinoma | 20 (10) | 11 (11) | 9 (9) | |
| Duodenal adenocarcinoma | 7 (3) | 3 (3) | 4 (4) | |
| IPMNd | 14 (7) | 6 (6) | 8 (8) | |
| NECe | 1 (1) | 0 | 1 (1) | |
| NETf | 3 (2) | 1 (1) | 2 (2) | |
| Other benign | 9 (4) | 5 (5) | 4 (4) | |
| Chronic pancreatitis | 10 (5) | 4 (4) | 6 (6) | |
| Others | 11 (5) | 3 (3) | 8 (8) | |
| Duration of symptom, month | 0.994 | |||
| Median | 1 (0–60) | 0.8 (0–27) | 1 (0–60) | |
| Symptom | ||||
| No symptom | 14 (7) | 5 (5) | 9 (9) | 0.407 |
| Jaundice | 129 (63) | 66 (645) | 63 (62) | 0.773 |
| Epigastric pain | 88 (43) | 47 (46) | 41 (40) | 0.481 |
| Body weight loss | 63 (31) | 39 (38) | 24 (24) | 0.034 |
| Nausea/vomiting | 50 (24) | 25 (24) | 25 (25) | 1.000 |
| Gastrointestinal bleeding | 13 (6) | 6 (6) | 7 (7) | 0.783 |
| Diabetes Mellitus | 44 (22) | 22 (21) | 22 (22) | 1.000 |
a
PJ: pancreaticojejunostomy.
b
PG: pancreaticogastrostomy.
c
CBD: common bile duct.
d
IPMN: intraductal papillary mucinous neoplasm.
e
NEC: neuroendocrine carcinoma.
f
NET: neuroendocrine tumor.